PLUS vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

PLUS

43.6
AI Score
VS
DBD Wins

DBD

54.7
AI Score

Investment Advisor Scores

PLUS

44score
Recommendation
HOLD

DBD

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PLUS DBD Winner
Forward P/E 16.7785 12.1655 DBD
PEG Ratio 1.0478 0 Tie
Revenue Growth 1.0% 1.7% DBD
Earnings Growth -28.0% 34.2% DBD
Tradestie Score 43.6/100 54.7/100 DBD
Profit Margin 4.9% 2.9% PLUS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PLUS 1M: +0.0% · 3M: +5.7% DBD 1M: -19.6% · 3M: -3.4%

Current Technical Phase

PLUS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.5 · Price: $86.85

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $69.94

Fundamentals Snapshot

Metric PLUS DBD
Market Cap
Forward P/E 15.7 10.0
Trailing P/E 18.6 22.3
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% 0.1%
EPS 4.67 3.04
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.